Loading patent…
OwnerCong Nhan HUYNHinventor
Estimating the term…
Metalloproteins on the surface of pathogenic microorganisms have Zn ion-high density, these Zn ions help pathogenic microorganisms to bind to metal ions on metalloproteins on host cell surface (similar to Zn ions find and bind to other metal ions in electric batteries with Zn-other metal electrode pairs). Pathogenic microorganisms and their fragments release Zn-rich products into the host body, these Zn-rich products rapidly make chelators with Zn ions-holding feature (which are mainly derivative of polyamines/ aminopolycarboxylic acids) fully hold Zn ions, deplete these active chelators, when active chelators are depleted, Zn-rich products bind to host metalloproteins, generating most symptoms, then host body provide new active chelators which separate Zn-rich products from host metalloproteins, repelling most symptoms. Drugs of invention contains chelators with strong Zn ion-holding feature (which are derivative of polyamines/aminopolycarboxylic acids) that have the following effects:—rapidly reduces most symptoms;—weaken microorganisms and loses their ability to bind to host cells;—strengthen host immune system;—clears the accumulation of Zn-rich products from host metalloproteins, repelling most symptoms;—repelling post-disease syndrome;—and so on. Drugs of invention contains [high active chelators+agent that creates strong physical effects (in treated tissues)] to treat diseased tissues (such as bacterial infection tissues/necrotic tissues/fungal infection tissues/benign tumors/cancerous tumors) with outstanding effectiveness.
Pharmaceuticals containing chelators/combinations of chelators, with chelators that have the effect of holding Zn ion/other transition metal ions, in which chelators are salts formed from polyamine with aminopolycarboxylic acid/salts formed from aminopolyol with aminopolycarboxylic acid/salts formed from polyamine with acid having at least 2 carboxyl functional groups in the molecule/salts formed from polyamine with acid having at least 2 hydroxyl groups in molecule/salts formed from polyamine and acid having at least 1 sulfur-containing functional group in the molecule/salts formed from polyamine with ascorbic acid/Mg aminopolycarboxylate salt/Ca aminopolycarboxylate salt/Cu aminopolycarboxylate salt/Fe aminopolycarboxylate salt/Ag aminopolycarboxylate salt/other aminopolycarboxylic acid derivatives in which other aminopolycarboxylic acids participate to form the derivatives of aminopolycarboxylic acids are aminopolycarboxylic acids with at least 3 carboxyl groups in the molecule/other derivatives of aminopolycarboxylic acids in which aminopolycarboxylic acids participate in forming other derivatives of aminopolycarboxylic acid that are aminopolycarboxylic acids having at least 3 carboxyl-containing groups in the molecule/other derivatives of polyamines in which polyamines participate in forming other polyamine derivatives that are polyamines having at least 4 nitrogen-containing functional groups in the molecule, and the pharmaceuticals are used for the following purposes:
Dependencies are inferred from the claim text.